Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Page 1
Is the CRAFITY score a superior predictor of prognosis and adverse events in hepatocellular carcinoma patients treated with locoregional-immunotherapy?
Hepatol Int. 2023 Oct;17(5):1279-1288. doi: 10.1007/s12072-023-10535-8. Epub 2023 May 2.
Hepatol Int. 2023.
PMID: 37129721
Vessels encapsulating tumor clusters: a novel efficacy predictor of hepatic arterial infusion chemotherapy in unresectable hepatocellular carcinoma.
Lin W, Lu L, Zheng R, Yuan S, Li S, Ling Y, Wei W, Guo R.
Lin W, et al.
J Cancer Res Clin Oncol. 2023 Dec;149(19):17231-17239. doi: 10.1007/s00432-023-05444-0. Epub 2023 Oct 6.
J Cancer Res Clin Oncol. 2023.
PMID: 37801135
Item in Clipboard
Comparative efficacy of PD-1 inhibitors plus lenvatinib and regorafenib after lenvatinib failure for advanced hepatocellular carcinoma: a real-world study.
Guan R, Mei J, Li S, Lin W, Deng M, Wei W, Guo R.
Guan R, et al.
Hepatol Int. 2023 Jun;17(3):765-769. doi: 10.1007/s12072-022-10470-0. Epub 2023 Jan 7.
Hepatol Int. 2023.
PMID: 36609671
No abstract available.
Item in Clipboard
Cite
Cite